Replies to post #4354 on GW Pharmaceuticals Plc ADS (GWPH)

[erdos47]

just an example - Fortune magazine article fron April 6 discusses the prospect of dea rescheduling. It would make it easier to conduct research. It really should be lower than sch. 2, if you look at what drugs are on 3 and 4. The problem for GW is that sch. 1 states NO accepted medical use.